TRENDING NOW

Ope­nAI-backed start­up re­leas­es new AI mod­els, claim­ing top per­for­mance in mak­ing an­ti­bod­ies

Ap­ple Tree Part­ner­s' biotechs 'face im­mi­nent col­lapse' as firm bat­tles Russ­ian in­vestor in court

Ab­b­Vie bags Cap­stan’s in vi­vo CAR-T work with $2.1B buy­out deal

Mod­er­na's Phase 3 flu vac­cine ef­fi­ca­cy in line with com­peti­tors, tee­ing up new sub­mis­sions

Am­gen’s stom­ach can­cer drug boosts sur­vival in Phase 3, but oc­u­lar side ef­fects leave ques­tions

J&J dealt blow in fight over its 340B re­bate mod­el

A service from the Financial Times